Form 8-K - Current report:
SEC Accession No. 0001437749-24-034889
Filing Date
2024-11-13
Accepted
2024-11-13 16:01:26
Documents
18
Period of Report
2024-11-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K crvo20241113_8k.htm   iXBRL 8-K 33139
2 EXHIBIT 99.1 ex_747440.htm EX-99.1 121972
3 EXHIBIT 99.2 ex_747441.htm EX-99.2 18261
4 EXHIBIT 99.3 ex_747442.htm EX-99.3 11035
9 cervomed01.jpg GRAPHIC 8620
  Complete submission text file 0001437749-24-034889.txt   353386

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA crvo-20241108.xsd EX-101.SCH 3410
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE crvo-20241108_def.xml EX-101.DEF 11425
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE crvo-20241108_lab.xml EX-101.LAB 15311
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crvo-20241108_pre.xml EX-101.PRE 11585
20 EXTRACTED XBRL INSTANCE DOCUMENT crvo20241113_8k_htm.xml XML 2819
Mailing Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116
Business Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116 (617) 744-4400
CervoMed Inc. (Filer) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37942 | Film No.: 241453853
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)